Kelsey Limesand
Nurse Practitioner · Jamestown, NDNPI 1518629393
Payments from drug & device makers
Across 68 payments — averaging $14.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$150
- Pfizer$144
- E.r. Squibb & Sons, L.L.C.$71
- Novo Nordisk$65
- Novartis$60
- Biohaven Pharmaceutical Holding Company Ltd.$55
- plus $471 from 18 others
What the payments were for
- Food & beverage$1,016100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 10 | $150 |
| Pfizer | 10 | $144 |
| E.r. Squibb & Sons, L.L.C. | 4 | $71 |
| Novo Nordisk | 5 | $65 |
| Novartis | 4 | $60 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $55 |
| AbbVie | 3 | $49 |
| Merck | 3 | $47 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $46 |
| Lilly USA, LLC | 3 | $44 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $32 |
| Boston Scientific | 1 | $32 |
| Boehringer Ingelheim | 2 | $29 |
| AstraZeneca | 2 | $27 |
| Johnson & Johnson | 2 | $27 |
| Teva Pharmaceuticals USA, Inc. | 2 | $27 |
| GSK | 1 | $19 |
| Collegium Pharmaceutical, Inc. | 1 | $16 |
| Axsome Therapeutics, Inc. | 1 | $15 |
| Actelion Pharmaceuticals US, Inc. | 1 | $15 |
| Medtronic | 1 | $15 |
| Lundbeck LLC | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $9 |
| Organon | 1 | $8 |
How this compares
$1,016 in reported general payments places this provider in the 85th percentile of 455 nurse practitioner providers in North Dakota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 36 | $261 |
| Metolazone | 28 | $220 |
| Doxycycline Hyclate | 21 | $189 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 14 | $105 |
| Prednisone | 51 | $96 |
| Azithromycin | 26 | $89 |
| Cephalexin | 20 | $71 |
| Ondansetron Hcl | 13 | $28 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Jamestown
- Todd McDowellJamestown$1K
- Emily GreensteinFargo$271K
- Sarah MatchaFargo$17K
- Jana SuderFargo$16K
- Lisa ClairmontBismarck$15K
- Jenna KelschMinot$9K
- McKinzie NussBismarck$7K
- Nicole MorganGrand Forks$7K
- Paula MochBismarck$5K
- Trina KaiserBismarck$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.